Ireland· IE-PA-PA1347/109/001
Ranolazine Krka 375 mg prolonged-release tablets
A ranolazine product containing ranolazine, registered in Ireland by KRKA, d.d., Novo mesto. The same ATC class is registered in 16 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Ranolazine is registered in 16 of 19 countries.
Countries holding a registration under ATC C01EB18 (ranolazine), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 10 of them publish a price we can compare per daily dose
Ranolazine · ATC C01EB18
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ranolazine costs, country by country.
Normalised to the WHO defined daily dose (1.5 g), the median price runs from $0.49 in United States to $5.07 in Switzerland — a ×10 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Ranolazine · price per daily dose (1.5 g)
USD · FX 28 Sept 2026
- CH Switzerland$5.07
- ES Spain$1.58
- IT Italy$0.87
- US United States$0.49 (acquisition cost)
The record
At a glance
HPRA (Ireland)- Active substance
- Ranolazine
- Manufacturer
- KRKA, d.d., Novo mesto
- Country
- Ireland (IE)
- ATC code
- C01EB18
- ATC class
- Ranolazine
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1347/109/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
335 interactions on record for ranolazine.
Graded by severity as the source publishes them — 78 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ranolazine · interactions on record
335 records
- 78 severe
- 205 moderate
- 29 minor
- 23 info
Most severe, free to view
- ClotrimazoleA01AB18severe
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ranolazine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainLABIGAT 375 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFGPharmathen S.A.
- United KingdomAnzipro 375mg modified-release tabletsRidge Pharma Ltd
- CzechiaRANEXAMenarini International Operations Luxembourg S.A., Luxembourg
- NetherlandsLazela 375 mg, tabletten met verlengde afgifteDemo S.A. Pharmaceutical Industry
- ItalyRANEXAMENARINI INTERNAT. O.L.S.A
- PolandRalikFarmak International Sp. z o.o.
- NorwayRanexaMenarini
- SwedenRanexa 375 mg DepottablettMenarini International Operations Luxembourg SA
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Rande, Ranogelan
- Bulgaria · Равена
- Cyprus · Ranolazine Accord, Ranolazine Remedica
- Czechia · Ranolazine Umedica
- Germany · Halibrell, Labigat
- Denmark · Labigat
- Estonia · Halibrell, Ralik
- Spain · Labigat, Ranolazina Alter
- France · Ranolazine Micro Labs
- United Kingdom (Northern Ireland) · Ranolazine, Ranolazine Accord
- Greece · Labigat, Lakosun
- Croatia · Halibrell, Lasokun
- Iceland · Ranexa
- Italy · Labigat, Ranolazina Accord
- Liechtenstein · Ranexa
- Lithuania · Halibrell, Lasokun
- Latvia · Halibrell, Lasokun
- Netherlands · Lazela, Ranogelan
- Norway · Ranexa
- Poland · Ralik, Ranolazine Aurovitas
- Portugal · Ranolazina Adamed, Ranolazina Bluepharma
- Romania · Ranolazina Atb
- Slovenia · Halibrell, Ranolazin Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/16bd06d6-7002-49b4-80cf-e1eca35e4b60 GET /v1/drugs/16bd06d6-7002-49b4-80cf-e1eca35e4b60?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Prolonged-release tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"C01EB18"
],
"strength": null,
"pa_number": "PA1347/109/001",
"substances": [
"Ranolazine"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "31/03/2023",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": "IC0168-205-024"
}See everything about ranolazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.